`
`First Named Inventor
`
`Tomoaki TAKEMURA
`
`SerialNo.NEW
`
`Filed September 22, 2014
`
`SURGERY ASSISTANCE DEVICE AND
`SURGERY ASSISTANCE PROGRAM
`
`[Corresponding to PCT/JP2013/002065
`Filed March 26, 2013]
`
`:
`
`:
`
`:
`
`Attorney Docket No. 2014-1274A
`
`14/387,160
`
`Mail Stop: PCT
`
`INFORMATION DISCLOSURE STATEMENT
`
`Commissioner for Patents
`
`PO. Box 1450
`
`Alexandria, VA 22313-1450
`
`Sir/Madam:
`
`Pursuant to the provisions of 37 CFR 1.56, 1.97 and 1.98, Applicant requests
`
`consideration of the information listed on attached Form PTO/SB/08.
`
`1a.
`
`[X] This Information Disclosure Statement is submitted:
`
`Within three months of the filing date (or of entry into the National Stage) of the above-
`
`entitled application, or
`
`before the mailing of a first Office Action on the merits or the mailing of a first Office
`
`Action after the filing of an RCE,
`
`and thus no certification and/0r fee is required.
`
`1b.
`
`[] This Information Disclosure Statement is submitted
`
`The USPTO is hereby authorized to charge anyfees under 37 C.F.R. §§ 1.16, 1.17, and 1.492, which may be required by this
`paper to Deposit Account No. 23-0975.
`ALL REFERENCES CONSiEEEEE‘: EXCEPT WHERE LiNEE) THROUGH.
`
`/A.E./
`
`
`
`after the events of above paragraph 1a and prior to the mailing date of a final Office
`
`Action or a Notice of Allowance or an action which otherwise closes prosecution in the
`
`application, and thus:
`
`(1) [] the certification of paragraph 2 below is provided, or
`
`(2)
`
`[] the fee of $180.00 ($90.00 for small entity) specified in 37 CFR l.l7(p) is
`
`enclosed.
`
`1c.
`
`[] This Information Disclosure Statement is submitted:
`
`after the mailing date of a final Office Action or Notice of Allowance or action which
`
`otherwise closes prosecution in the application, and prior to payment of the issue fee, and
`
`thus:
`
`the certification of paragraph 2 below is provided, M
`
`the fee of $180.00 ($90.00 for small entity) specified in 37 CFR l.l7(p) is enclosed.
`
`It is hereby certified
`
`a.
`
`[]
`
`that each item of information contained in this Information Disclosure
`
`Statement was first cited in any communication from a foreign patent office in a
`
`counterpart foreign application not more than three months prior to the filing of
`
`the Statement (37 CFR. § 1.97(e)(1)), or
`
`b.
`
`[]
`
`that no item of information contained in the Information Disclosure Statement
`
`was cited in a communication from a foreign patent office in a counterpart
`
`foreign application and, to the knowledge of the person signing the certification
`
`after making reasonable inquiry, was known to any individual designated in
`
`§1.56(c) more than three months prior to the filing of the Statement (37 CFR. §
`
`1.97(e)(2)).
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE UNEE} THRQUGH .
`
`/A.E./
`
`2
`
`
`
`3.
`
`For each non-English language reference listed on the attached Form PTO/SB/OS,
`
`reference is made to one or more of the following:
`
`a.
`
`b.
`
`c.
`
`[X]
`
`a full or partial English language translation submitted herewith,
`
`[X]
`
`two International Search Reports submitted herewith,
`
`[]
`
`a foreign patent office search report or office action (in the English language)
`
`submitted herewith,
`
`d.
`
`[X]
`
`the concise explanation contained in the specification of the present application
`
`at pages 1-2,
`
`e.
`
`f.
`
`[X]
`
`the concise explanation set forth in the attached English language abstract,
`
`[X]
`
`the concise explanation set forth on the attached Form PTO/SB/OS,
`
`4.
`
`[X] Two International Search Reports citing one or more of the references is enclosed.
`
`Respectfully submitted,
`
`/Jeffrey R. Filipek/
`2014.09.22 15:57:27 -O4'OO'
`
`
`Jeffrey R. Filipek
`Registration No. 4 l ,471
`Attorney for Applicant
`
`JRF/fs
`Washington, DC. 20005-1503
`Telephone (202) 721-8200
`Facsimile (202) 721-825 0
`September 22, 2014
`
`/Aii Bag/3U
`
`02/21/2015
`
`ALL REFERENCES SONSlQEREE‘: EXCEPT WHERE LiNEE) THRQUGH.
`
`/A.E./
`
`3
`
`